Jon P. Druhan
Affiliations: | AstraZeneca LP, Canóvanas, Canóvanas, Puerto Rico |
Google:
"Jon Druhan"Mean distance: 14.41 (cluster 19) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Walters CL, Aston-Jones G, Druhan JP. (2000) Expression of fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 307-15 |
Druhan JP, Walters CL, Aston-Jones G. (2000) Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal. The Journal of Pharmacology and Experimental Therapeutics. 294: 531-8 |
Franklin TR, Druhan JP. (2000) Expression of Fos-related antigens in the nucleus accumbens and associated regions following exposure to a cocaine-paired environment. The European Journal of Neuroscience. 12: 2097-106 |
Delfs JM, Zhu Y, Druhan JP, et al. (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature. 403: 430-4 |
Aston-Jones G, Druhan J. (1999) Behavioural pharmacology. Breaking the chain of addiction. Nature. 400: 317, 319 |
Druhan JP, Wilent WB. (1999) Effects of the competitive N-methyl-D-aspartate receptor antagonist, CPP, on the development and expression of conditioned hyperactivity and sensitization induced by cocaine. Behavioural Brain Research. 102: 195-210 |
Druhan JP, Geyer MA, Valentino RJ. (1998) Lack of sensitization to the effects of d-amphetamine and apomorphine on sensorimotor gating in rats. Psychopharmacology. 135: 296-304 |
Druhan JP, Walters CL, Aston-Jones G. (1998) ROLE OFTHE NUCLEUS ACCUMBENS IN THE ACUTE POTENTIATION OF D2 DOPAMINE RECEPTOR AGONIST EFFECTS OBSERVED DURING OPIATE WITHDRAWAL Behavioural Pharmacology. 9: S34 |
Druhan JP, Rajabi H, Stewart J. (1996) MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens. Synapse (New York, N.Y.). 24: 135-46 |
Druhan JP, Jakob A, Stewart J. (1993) The development of behavioral sensitization to apomorphine is blocked by MK-801. European Journal of Pharmacology. 243: 73-7 |